Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Heron Therapeutics Inc. is currently managing 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This specific matter is being handled within 1 distinct art unit, indicating a concentrated technical focus for the company's current patent activities. The presence of 1 distinct examiner suggests that the entirety of the company's active prosecution at this stage is subject to the discretion of a single official. This focus within Medical Devices & Mechanical Engineering may simplify the monitoring of prosecution trends, as there are no competing examiner styles to reconcile.
The busiest examiner for this portfolio is LANGE, ERIC A, who is responsible for 1 pending office action. Since there is only 1 pending office action in total, this examiner's decisions will have a definitive impact on the current state of the portfolio. The alignment of 1 distinct examiner with 1 distinct art unit ensures that the legal strategy remains focused on the specific requirements of that unit. Practitioners should focus on the specific preferences of LANGE, ERIC A, as this individual manages the company's 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LANGE, ERIC A | 1 | 77.6% | +12.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18606872 | VIAL ACCESS NEEDLE DEVICE | LANGE, ERIC A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18606872 | VIAL ACCESS NEEDLE DEVICE | LANGE, ERIC A | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18606872 | VIAL ACCESS NEEDLE DEVICE | LANGE, ERIC A | 3783 | §102§103§112 | Non-Final OA | — | Pending | Mar 15, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHeron Therapeutics Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Eric A Lange has the most, with 1 of Heron Therapeutics Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
